Bespoke Extracts (BSPK) Invested Capital (2013 - 2025)

Bespoke Extracts (BSPK) reported Invested Capital of $335190.0 for Q3 2025, down 32.96% sequentially from $500000.0 in Q3 2021.

Bespoke Extracts (BSPK) Invested Capital (2013 - 2025) Analysis & Trends

Bespoke Extracts (BSPK) has 9 years of Invested Capital data on file, last reported at $335190.0 in Q3 2025.

For the quarter ending Q3 2025, Invested Capital changed N/A year-over-year to $335190.0; the trailing twelve-month figure through Sep 2025 stood at $335190.0 (changed N/A YoY), and the FY2021 full-year result was $500000.0, changed 0.0% from the prior year.
Invested Capital declined to $335190.0 in Q3 2025, from $500000.0 in the prior quarter.
In the past five years, Invested Capital ranged from a high of $500000.0 in Q1 2021 to a low of $335190.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	1.11 Bn
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	2.61 Bn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	31.13 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	7.15 Bn
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	1.93 Bn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	73.00 Mn
10	Bespoke Extracts	1.12 Mn	1.11 Mn	234,175.00	335,190.00

Download Data